SCHEMBL2957555

SCHEMBL2957555

CCO[CH]Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714417 0.74
SCHEMBL172058 0.74
SCHEMBL6714410 0.74
Vinyl Chloride SCHEMBL27740258 0.70
SCHEMBL7636359 0.70
SCHEMBL11334518 0.70
SCHEMBL1407387 0.70
SCHEMBL8052611 0.70
SCHEMBL12226 0.70
SCHEMBL1407388 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1017430-B Process for the preparation of 7 beta- [2- (2-amino-4-thiazolyl) alkenamido ] -3-cephem-4-carboxylic acid esters SHIONOGI & CO (JP) 1992-07-15 CN claimed
US-10894239-B2 Dispersant, dispersion composition, and fibrous sheet MEISEI CHEMICAL WORKS, LTD. (JP) 2021-01-19 US disclosed
EP-3135369-B1 USE OF DISPERSANT,DISPERSION COMPOSITION AND FIBROUS SHEET MEISEI CHEMICAL WORKS LTD (JP) 2020-08-19 EP disclosed
US-20170080397-A1 DISPERSANT, DISPERSION COMPOSITION, AND FIBROUS SHEET MEISEI CHEMICAL WORKS, LTD. (JP) 2017-03-23 US disclosed
EP-3135369-A1 DISPERSANT, DISPERSION COMPOSITION, AND FIBROUS SHEET MEISEI CHEMICAL WORKS, LTD. (JP) 2017-03-01 EP disclosed
CN-103987711-B 8-carbamoyl-2- (2, 3-disubstituted pyridin-6-yl) -1,2,3, 4-tetrahydroisoquinoline derivatives as apoptosis inducers for the treatment of cancer and immune and autoimmune diseases 艾伯维公司 2016-08-24 CN disclosed
CN-102307872-B BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2016-06-15 CN disclosed
CN-103153993-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases ABBVIE INC. (BS) 2016-06-01 CN disclosed
CN-103402521-B Methods of treatment using selective BCL-2 inhibitors ABBVIE INC. (BS) 2016-01-20 CN disclosed
CN-105218483-A Be used for the treatment of the cell death inducer of cancer and immunity and autoimmune disorder ABBVIE INC 2016-01-06 CN disclosed
EP-0888271-A4 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LAB (US) 2000-03-15 EP disclosed
US-5994375-A ANTICOAGULANTS BERLEX LABORATORIES, INC. (US) 1999-11-30 US disclosed
CN-1211232-A Benzamidine derivatives substituted with amino acid and hydroxy acid derivatives and their use as anticoagulants BERLEX LAB (US) 1999-03-17 CN disclosed
EP-0888271-A1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (US) 1999-01-07 EP disclosed
WO-1997029067-A1 BENZAMIDINE DERIVATIVES SUBSTITUTED BY AMINO ACID AND HYDROXY ACID DERIVATIVES AND THEIR USE AS ANTI-COAGULANTS BERLEX LABORATORIES, INC. (DE) 1997-08-14 WO disclosed
US-5260444-A Cardiovascular, hypotensive WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1993-11-09 US disclosed
US-5208245-A Hypotensive agents WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1993-05-04 US disclosed
EP-0460418-A2 Novel Dihydropyridine derivative WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) 1991-12-11 EP disclosed
US-4332614-A HALOACETANILIDE ETHERS MONSANTO COMPANY (US) 1982-06-01 US disclosed
US-4183928-A Haloarylmalonamidooxacephalosporins SHIONOGI AND CO., LTD. (JP) 1980-01-15 US disclosed